Inmolecule Nanotech (XPAR:MLINA) Other Financing: €0.00 Mil (TTM As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Other Financing?

Inmolecule Nanotech XPAR:MLINA 6 Other Financing is €0.00 Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Inmolecule Nanotech's Other Financing for the six months ended in Dec. 2024 was €0.00 Mil.

Inmolecule Nanotech's Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.


Inmolecule Nanotech Other Financing Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Other Financing Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Other Financing
0.00 0.00

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Other Financing 0.00 0.00
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €0.00 Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Other Financing of €0.00 Mil as of Dec. 2024. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Other Financing too high?
Inmolecule Nanotech's current Other Financing is €0.00 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Other Financing compare to VRTX and REGN?
Inmolecule Nanotech's Other Financing of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Other Financing is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Other Financing of €0.00 Mil. The current Other Financing is €0.00 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Other Financing is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price